References

1. Sanders LJ. Diabetes mellitus: prevention of amputation. J Am Podiatr Med Assoc 1994;84(7):322-328.

2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26(3):917-932.

3. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-387.

4. Palumbo PJ, Melton LJ. Peripheral vascular disease and diabetes, in Diabetes in America (Harris MI, Hamman RF, eds.), Govt. Printing Office, Washington, DC, US, 1985, pp. XV1- XV21.

5. Borssen B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet Med 1999;7:438-444.

6. Kumar S, Asche HA, Fernando DJ. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994;11:480-484.

7. Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Int Med 1992;152:610-616.

8. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower extremity lcers. Diabetes Care 2000;23:1333-1338.

9. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larson J. Diabetic foot ulcers in a multi-disciplinary setting: an economic analysis of primary healing and healing with amputation. J Int Med 1994;235:463-471.

10. Reiber GE, Boyko E, Smith DG. Lower extremity ulcers and amputations in individuals with diabetes, in Diabetes in America (Boyko EJ, Reiber GE, Bennett PH, eds.), Govt. Printing Office, Washington, DC, US, 1995, pp. 409-427.

11. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:513-521.

12. Reiber GE, Pecorraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case-control study. Ann Int Med 1992;117:97-105.

13. Lehto S, Pyorala K, Ronnemaa T, Laakso M. Risk factors predicting lower extremity amputations in Patients with NIDDM. Diabetes Care 1996;19:607-612.

14. Nelson RG, Gohdes DM, Everhart JE, et al. Lower extremity amputations in NIDDM: 12 year follow-up study in Pima Indians. Diabetes Care 1988;11:8-16.

15. Sittonen OL, Niskanen LK, Laakso M, Tiitonen J, Pyorala K. Lower extremity amputations in diabetic and nondiabetic patients. Diabetes Care 1988;11:8-16.

16. Resnick HE, Valsania P, Phillips CL. Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: The National Health and Nutrition Examination Survey epidemiologic follow-up study, 1971-1992. Arch Int Med 1999;159:2470-2475.

17. Wrobel JS, Mayfield JA, Reiber GE. Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care 2001;24:1-5.

18. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91.

19. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States, 2003. Bethesda, MD: US Department of Health and Human Services, National

Institutes of Health, 2003. Rev. ed. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 2004.

Flegal KM, Ezzati TM, Harris M, et al. Prevalence of diabetes in Mexican Americans, Cubans and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care 1991;14:628-638.

Roseman JM. Diabetes in black Americans, in Diabetes in America, Govt. Printing Office, Washington, DC, US, 1985.

Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. J Med 1986;60:763-771. Lippmann HI. Must loss of a limb be a consequence of diabetes mellitus? Diabetes Care 1979;2:432-436.

Reiber GE. Diabetic foot care: guidelines and financial implications. Diabetes Care 1992;15:29-31.

Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2002. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003.

Bakker K, Rauwerda JA, Schaper NC. Diabetes Metab Res Rev 2000;16(Suppl 1):S1. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994; 17:557-560.

Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle prospective diabetic foot study. Diabetes Care 1997;96:223-228.

Ward JD, Simms JM, Knight G, Boulton AJ, Sandler DA. Venous distension in the diabetic neuropathic foot. JR Soc Med 1983;76:1011-1014.

Boulton AJ, Scarpello JH, Ward JD. Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting? Diabetologia 1982;22:6-8.

Tegner R. The effect of skin temperature on vibratory sensitivity in polyneuropathy. J Neurol Neurosurg Psychiatr 1985;48:176-178.

Boulton AJ, Hardisty CA, Betts RP, et al. Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983;1:26-33. Stokes IA, Furis IB, Hutton WC. The neuropathic ulcer and loads on the foot in diabetic patients. Acta Orthop Scand 1975;46:839-847.

Ctercteko G, Dhanendran M, Hutton WC, et al. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981;68:608-614. Veves A, Fernando DJ, Walewski P, et al. A study of plantar pressures in a diabetic clinic population. Foot 1991;2:89-92.

Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991;14(1):8-11. Caselli A, Pham HT, Giurini JM, Armstrong DG, Veves A. The forefoot/rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care 2002;25:1066-1071.

Veves A, Murray HJ, Young MJ, et al. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660-663.

Kelly PJ, Coventry MB. Neurotrophic ulcers of the feet: review of 47 cases. JAMA 1958;

168:388.

Sarnow MR, Veves A, Giurini JM, et al. In-shoe foot pressure measurements in diabetic patients with at-risk feet and in healthy subjects. Diabetes Care 1994;17:1002-1006.

42. Crisp AJ, Heathcote JG. Connective tissue abnormalities in diabetes mellitus. J R Coll Phys 1984;18:132-141.

43. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: rose in the pathogenesis of diabetic complications. Clin Chem 1986;32:B37-B41.

44. Delbridge L, Perry P, Marr S, et al. Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med 1988;5:333-337.

45. Mueller MJ, Diamond JE, Delitto A, Sinacore DR. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther 1989;69:453-462.

46. Birke JA, Franks BD, Foto JG. First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle 1995;16:277-284.

47. Veves A, Sarnow MR, Giurini JM, et al. Differences in joint mobility and foot pressures between black and white diabetic patients. Diabet Med 1995;12:585-589.

48. Grant WP, Sullivan R, Soenshine DE, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg 1997;36:272-278.

49. Armstrong DG, Stacpoole-Shea S, Nguyen HC, Harkless LB. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg 1999;81A:535-538.

50. D'Ambrogi E, Giurato L, D'Agostino MA, et al. Contribution of plantar fascia to the increased forefoot pressures in diabetic patients. Diabetes Care 2003;26(5):1525-1529.

51. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-949.

52. Rayman G, Williams SA, Spencer PD, et al. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. BMJ 1986;292:1295-1298.

53. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.

54. Veves A, Akbari, CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-463.

55. Arora S, Smakowski P, Frykberg RG, Freeman R, LoGerfo FW, Veves A. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 1998;21:1339-1344.

56. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-1862.

57. Szabo C, Zanchi A, Komjati K, et al. Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002;106:2680-2686.

58. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501-505.

59. Caselli A, Rich J, Hanane T, Uccioli L, Veves A. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurol 2003;60:297-300.

60. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 2001;24:344-349.

61. Parkhouse N, LeQueen PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988;318:1306-1309.

62. Schilling JA. Wound healing. Physiol Rev 1968;48:374-423.

63. Cooper DM, Yu EZ, Hennesey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994;219:688-692.

64. Zykova SN, Jenssen TG, Berdal M, et al. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000;40:1451-1458.

65. Spravchikov N, Sizyakov G, Gartsbein M, et al. Glucose effects on skin keratinocytes. Diabetes 2001;50:1627-1635.

66. Jude EB, Boulton AJ, Ferguson MW, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999;42:748-757.

67. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in Cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111:850-857.

68. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. Diabetes Care 1992;22:1036-1042.

69. Boyko E, Ahroni JH, Stensel V, et al. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-1042.

70. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventative foot care in people with diabetes. Diabetes Care 1998;21:2161-2177.

71. Boulton AJ, Gries FA, Jervell J. Guidelines for the diagnosis and outpatient management of diabetic periperal neuropathy. Diabet Med 1998;15:508-514.

72. Helm PA, Walker SC, Pulliam GF. Recurrence of neuropathic ulcerations following healing in a total contact cast. Arch Phys MedRehabil 1991;72:967-970.

73. Thompson FJ, Veves A, Ashe H, et al. A team approach to diabetic foot care-the Manchester experience. Foot 1991;1:75-82.

74. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991;13:63-67.

75. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration. Diabetes Care 2000;23:606-611.

76. McNeely MJ, Boyko E, Ahroni JH. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 1995;18:216-219.

77. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar pressures in diabetic patients. Diabetic Med 1992;9:55-57.

78. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2:64.

79. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996;36:528-531.

80. Armstrong DG, Lavery L, Harkless LB. Validation of a diabetic wound classification system. Diabet Med 1998;21:855-859.

81. Steed DL, Donohoe D, Wbster MW, Lindsley L. Diabetic Ulcer Study Group. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996;183:61-64.

82. Clark RAF. Mechanisms of cutaneous wound repair, in Hematology in General Medicine (Fitzpatrick TB, et al., eds.), McGraw-Hill, New York, 1993.

83. Bale S. A guide to wound debridement. J Wound Care 1997;6:179-182.

84. Armstrong DG, Nguyen HC, Lavery LA, et al. Offloading the diabetic foot wound: A randomized clinical trial. Diabetes Care 2001;24:1019-1022.

85. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers. Diabetes Care 1989;12:364-387.

86. Lavery LA, Vela SA, Lavery DC, et al. Reducting dynamic foot pressures in high-risk diabetics with foot ulcerations: A comparison of treatments. Diabetes Care 1996;19:818-821.

87. Birke JA, Fred B, Krieger LA, Sliman K. The effectiveness of an accommodative dressing in offloading pressure over areas of previous metatarsal head ulceration. Wounds 2003;15:33-39.

88. Cheung Y, Hochman M, Brophy DP. Radiographic Changes in the Diabetic Foot. in The Diabetic Foot (Veves A, Giurini JM, Logerfo FW, eds.), Humana Press, Totowa, NJ, 2002, pp. 179-205.

89. Bonakdar-Pour A, Gaines VD. The radiology of osteomyelitis. Orthop Clin North Am 1983;14:21-37.

90. Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am 1990;4:409-432.

91. Karchmer AW. Microbiology and treatment of diabetic foot infections, in The Diabetic Foot. Medical and Surgical Management (Veves A, Giurini JM, LoGerfo FW, eds.), Humana Press, Totowa, NJ, 2002, pp. 207-220.

92. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Int Med 1990;150:790-797.

93. Jones EW, Edwards R, Finch R, Jaffcoate WJ. A microbiologic study of diabetic foot lesions. Diabet Med 1984;2:213-215.

94. Field FK, Kerstein MD. Overview of wound healing in a moist environment. Am J of Surg 1994;167(1A):2S-6S.

95. Cooper DM, Yu EZ, Hennesey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994;219:688-692.

96. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 1998;21:822-827.

97. Muhart M, McFalls S, Kirsner RS, et al. Behavior of tissue-engineered skin. Arch Dermatol 1999;135:913-918.

98. Hansbrough JF, Dore C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992;13:519-529.

99. Cooper ML, Hansbrough JF, Spielvogel RL, et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-248.

100. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-354.

101. Eaglstein WH, Iriondo M, Laszio K. A composite skin substitute (Graftskin) for surgical wounds: a clinical experience. Dermat Surg 1995;21:839-834.

102. Brem H, Balledux J, Bloom T, Kerstein M, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent. Arch Surg 2000;135:627-634.

103. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 2001;24:290-295.

104. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plasti Reconstr Surg 2006;(7 Suppl):2395-2445.

105. Chanteleau E, Kushner T, Spraul M. How effective is cushioned therapeutic footwear in protecting diabetic feet. Diabet Med 1990;7:355-359.

106. Veves A, Masson EA, Fernando DJ, Boulton AJ. Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care 1989;12: 653-655.

107. Gudas CJ. Prophylactic surgery in the diabetic foot. Clin Podiatr Med Surg 1987;4: 445-458.

108. Tillo TH, Giurini JM, Habershaw GM, Chrzan JS, Rowbotham JL. Review of metatarsal osteotomies for the treatment of neuropathic ulcerations. J Am Podiatr Med Assoc 1990; 80:211-217.

109. Giurini JM, Basile P, Chrzan JS, Habershaw GM, Rosenblum BI. Panmetatarsal head resection: a viable alternative to the transmetatarsal amputation. J Am Podiatr Med Assoc 1993;83:101-107.

110. Giurini JM, Rosenblum BI. The role of foot surgery in patients with diabetes. Clin Podiatr Med Surg 1995;12:119-127.

111. Rosenblum BI, Giurini JM, Chrzan JS, Habershaw GM. Preventing loss of the great toe with the hallux interphalangeal joint arthroplasty. J Foot Ankle Surg 1994;33:557-560.

112. Gibbons GW. The diabetic foot: amputations and drainage of infection. J Vasc Surg 1987; 5:791-793.

113. Taylor LM, Porter JM. The clinical course of diabetic patients who require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987;6:454-459.

114. Attinger CE. Use of soft tissue techniques for the salvage of the diabetic foot, in Medical and Surgical Management of the Diabetic Foot (Kominsky SJ, ed.), Mosby-Year Book, Boston, 1994.

115. Edmonds M, Foster A, Oreenhill M, et al. Acute septic vasculitis not diabetic micro antiopa-thy leads to digital necrosis in the neuropathic foot. Diabet Med 1992;9(Suppl l):P85.

116. Charcot JM. Sur quelques arthropathies qui paraissent dependre d'une lesion du cerveau ou de la moelle epiniere. Arch Physiol Norm Pathol 1868;1:61.

117. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: Charcot Foto, in The High Risk Foot in Diabetes Mellitus (Frykberg RG, ed.), Churchill Livingsto ne, New York, 1991, pp. 297-338.

118. Delano PJ. The pathogenesis of Charcot's joint. AJR 1946;(56)2:189-200.

119. Edmonds ME, Roberts VC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia 1982;22:9-15.

120. Edelman SV, Kosofsky EM, Paul RA, et al. Neuro-osteoarthropathy (Charcot's joint) in diabetes mellitus following revascularization surgery: three case reports and a review of the literature. Arch Int Med 1987;147:1504-1508.

121. Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy (Charcot joints) in diabetes mellitus: clinical study of 101 cases. Medicine 1972;52:191-210.

122. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: Charcot Foot, in The High Risk Foot in Diabetes Mellitus (Frykberg RG, ed.), Churchill Livingsto ne, New York, 1991, pp. 297-338.

123. Giurini JM, Chrzan JS, Gibbons GW, Habershaw GH. Charcot's disease in diabetic patients. Postgrad Med 1991;89:163-169.

124. Frykberg RG. Charcot Changes in the Diabetic Foot, in The Diabetic Foot (Veves A, Giurini JM, LoGerfo FW, eds.), Humana Press, Totawa, 2002, pp. 221-246.

125. Simon S, Tejwani S, Wilson D, et al. Arthrodesis as an alternative to nonoperative management of charcot arthropathy of the diabetic foot. JBJS 2000;82A:939-950.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook


Post a comment